Geology Reports⌕ Search

Geology topics

Kimberli J.G. Miller

Publications and source records attributed to Kimberli J.G. Miller.

At least 19 recordsLinked to original sources
USGS2026

Aspergillosis (Avian) case definition for wildlife

Diagnostic laboratories receive carcasses and samples for diagnostic evaluation and pathogen/toxin detection. Case definitions bring clarity and consistency to the evaluation process. Their use within and between organizations allows more uniform reporting of diseases and etiologic agents. The intent of a case definition is to provide scientifically based criteria for determining: (a) if an individual carcass has a specific disease and degree of confidence in that diagnosis and (b) if there is evidence of a pathogen or toxin in a carcass or sample (for example, swab, tissue sample, skin scraping, blood/serum sample, environmental sample, or other). This case definition is specific to aspergillosis and applies to all avian species.

Techniques and Methods↗
USGS2024

Case definitions for wildlife diseases

Welcome to the first manual of “Case Definitions for Wildlife Diseases,” a “living” electronic publication. The plan is to add and update this manual’s case definitions periodically as warranted; thus, this manual will never be completed, and readers should download the latest versions of specific chapters (that is, definitions) when available. Constructive suggestions from readers are welcome and will help guide adjustments as this project progresses. The purpose of this manual is to provide case definitions for selected diseases of importance to wildlife in Canada and the United States. Case definitions provide standard sets of criteria for classifying the degree of certainty of a particular diagnosis and help improve surveillance data quality and comparability. Better data and standardization allow for improved data sharing, which increases geographic and species surveillance coverage and permits more robust analyses. The definitions included in this manual have been developed by veterinary pathologists, epidemiologists, and wildlife biologists primarily from the U.S. Geological Survey National Wildlife Health Center (NWHC) and Canadian Wildlife Health Cooperative (CWHC). Pathologists from each organization reviewed and finalized the definitions. Each case definition has been peer reviewed by two scientific experts before publication. This manual begins with the case definition template. This generic template includes four sections: “Individual, Place, and Time Criteria for Diagnosis and Testing,” “Field Criteria for Diagnosis,” “Laboratory Criteria for Diagnosis,” and “Epidemiological Linkage Criteria for Diagnosis” and can be used to guide development of new case definitions. Information in each section is then combined to provide an overall case classification. Disease diagnoses are classified as “Confirmed,” “Presumptive,” or “Suspected;” and evidence of a pathogen or toxin is classified as “Exposed” or “Present/Detected.” Each subsequent chapter is then a case definition for a specific disease of wildlife, and infectious and non-infectious diseases are included.

Techniques and Methods↗
USGS2024

[Disease/condition] case definition [template] for wildlife

Diagnostic laboratories receive carcasses and samples for diagnostic evaluation and pathogen/toxin detection. Case definitions bring clarity and consistency to the evaluation process. Their use within and between organizations allows more uniform reporting of diseases and etiologic agents. The intent of a case definition is to provide scientifically based criteria for determining (a) if an individual carcass has a specific disease and degree of confidence in that diagnosis and (b) if there is evidence of a pathogen or toxin in a carcass or sample (for example, swab, tissue sample, skin scraping, blood/serum sample, environmental sample, or other). This case definition template can be used for any disease/pathogen for any species. An editable version of this template is available for download at https://doi.org/10.3133/tm19A1 .

Techniques and Methods↗
USGS2022

WHISPers—Providing situational awareness of wildlife disease threats to the Nation—A fact sheet for the biosurveillance community

Solutions for emerging infectious disease and bioterror threats can be improved by incorporating integrated biodefense strategies, including improved surveillance for animal and zoonotic diseases, strong national leadership, and effective management tools. Active biosurveillance for disease events is key to early detection, warning, and overall situational awareness and enables better communication, coordination, decision making, and data-driven responses. The national biosurveillance infrastructure has well-established channels for human and domestic animal health data through the Centers for Disease Control and Prevention and U.S. Department of Agriculture, and State, county, and local authorities. Wildlife disease information, however, has been more challenging to acquire and access, in part, due to the comparatively small infrastructure and resources dedicated to wildlife health and also because regulatory authority for wildlife and wildlife health is split among Federal, State, Tribal, and indigenous natural resource authorities. To address these issues, the Wildlife Health Information Sharing Partnership-event reporting system (WHISPers; https://whispers.usgs.gov ) was developed by the U.S. Geological Survey National Wildlife Health Center to promote collaboration and sharing of wildlife health information and to provide situational awareness and timely information about wildlife disease threats. WHISPers is a free science gateway and data portal that provides interactive query, display, reporting, and export capabilities for wildlife health event summary information.

Fact Sheet↗
USGS2020

Postmortem evaluation of reintroduced migratory whooping cranes (Grus americana) in eastern North America

We reviewed necropsy records of 124 Whooping Cranes ( Grus americana ) recovered following reintroduction of 268 individuals from 2001 to 2016 in the eastern US. Causes of death were determined in 62% (77/124) of cases facilitated by active monitoring that limited decomposition and scavenging artifact. The greatest proportions of mortality were caused by predation (0.468; 95% confidence interval 0.356–0.580; 36/77), collision with power lines or vehicles (0.260; 0.162–0.358; 20/77), and gunshot (0.169; 0.085–0.253; 13/77). Six deaths were attributed to infection (0.078; 0.018–0.138; 6/77), including bacterial and fungal etiologies. Lead analysis of 50 liver samples yielded two results with elevated concentrations (3.65 and 10.97 ppm wet weight), and 10 bone samples from partial carcasses lacking suitable liver tissue resulted in one elevated result (48.82 ppm dry weight). These data indicate that underlying subclinical or clinical lead toxicosis may be a factor in up to 5% of deaths attributed to predation or impact trauma. Brain cholinesterase activity testing indicated no exposure to organophosphate or carbamate pesticides (mean±SD=17.32±2.90 µmol/min/g, 31/71). The causes of death and potential underlying factors summarized in this study constitute the first definitive mortality survey of migratory Whooping Cranes based on a high carcass recovery rate. Causes of death by infectious etiologies remained comparatively rare in this study, and occurred as single cases with no evidence of sustained transmission among reintroduced Whooping Cranes.

Eastern North America↗
USGS2009

Pathogenicity of West Nile virus and response to vaccination in sandhill cranes ( Grus canadensis ) using a killed vaccine

West Nile virus was introduced into the United States in the vicinity of New York, New York, USA in 1999. The virus has since killed large numbers of birds nationwide, especially, but not limited to, crows ( Corvus brachyrhinchos ). One sandhill crane ( Grus canadensis ) at the Bridgeport Zoo (Bridgeport, Connecticut, USA) reportedly died from West Nile virus, so sandhill cranes and endangered whooping cranes ( Grus americana ), both in the wild and in captive breeding colonies at United States Geological Service (USGS) Patuxent Wildlife Research Center (Laurel, Maryland, USA) were considered at risk. A killed vaccine in sandhill cranes was evaluated by vaccinating and then challenging these cranes with live West Nile virus. No sandhill cranes inoculated with the killed vaccine developed significant titers when compared with unvaccinated controls. No sandhill cranes inoculated with the vaccine and challenged with the virus died from West Nile virus infection. In addition, no unvaccinated challenged sandhill cranes died. However, 2 days postchallenge, vaccinated cranes had significantly less viremia (P < 0.05) than unvaccinated cranes. Seven days postchallenge vaccinated cranes had significantly less cloacal shedding of the virus (P < 0.05) than unvaccinated cranes and significantly less weight loss (P < 0.05) as compared with unvaccinated cranes. Vaccinated sandhill cranes developed significantly higher titers 14 days postchallenge and were viremic for shorter periods of time after challenge than unvaccinated individuals. Unvaccinated challenged cranes had glial cell aggregates in both the brain and brain stem areas, and this was not observed in vaccinated challenged cranes or in vaccinated unchallenged cranes.

Journal of Zoo and Wildlife Medicine↗
USGS2003

Vacuolar myelinopathy in waterfowl from a North Carolina impoundment

Vacuolar myelinopathy was confirmed by light and electron microscopic examination of mallards (Anas platyrhynchos), ring-necked ducks (Aythya collaris), and buffleheads (Bucephala albeola) collected during an epizootic at Lake Surf in central North Carolina (USA) between November 1998 and February 1999. Clinical signs of affected birds were consistent with central nervous system impairment of motor function (incoordination, abnormal movement and posture, weakness, paralysis). This is the first report of this disease in wild waterfowl (Anseriformes).

North Carolina↗
USGS2002

Epizootiologic studies of avian vacuolar myelinopathy in waterbirds

Epizootic avian vacuolar myelinopathy (AVM) was first recognized as a neurologic disease in bald eagles (Haliaeetus leucocephalus) and American coots (Fulica americana) in Arkansas, USA in 1994 and 1996, respectively, but attempts to identify the etiology of the disease have been unsuccessful to date. Between 1998 and 2001, wing clipped sentinel birds (wild American coots and game farm mallards [Anas platyrhynchos]) were released at Lake Surf, North Carolina, a lake with recurrent outbreaks of AVM, in order to gain a better understanding of the epizootiology of the disease. As early as 5-7 days post-release, sentinel coots and mallards showed neurologic signs of disease and were confirmed with AVM upon histologic examination of their brains. Serial releases of sentinel mallards during the summer, fall, and winter of 2000-01 demonstrated that exposure to the causative agent at a threshold sufficient to manifest disease was seasonal and occurred over about a 2 mo period, during November and December. Our findings that disease onset can be very rapid (5-7 days) and that exposure to the causative agent of AVM is site-specific, seasonal (late fall to early winter), and occurs over a relatively short duration (several months) supports the hypothesis that the disease is caused by a chemical substance, most likely of natural origin.

North Carolina↗